Minimise transmission risk of CJD and vCJD in healthcare settings

Prevention of CJD and vCJD by Advisory Committee on Dangerous Pathogens' Transmissible Spongiform Encephalopathy (ACDP TSE) Subgroup.



Annex A2: Distribution of infectivity in animal tissue and body fluids

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.

Annex B: Diagnostic criteria

Annex F: Endoscopy

Annex H: After death

CJD guidance for ophthalmologists

Frequently asked questions




This guidance produced by the Advisory Committee on Dangerous Pathogens’ Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup aims to help minimise the risk of transmission of CJD and vCJD in healthcare and other work settings.